市場調查報告書

臉部注射器的全球市場預測:皮膚填充劑,抗老化/抗皺注射,拉皮,唇部營養護理

Facial Injectors Market Information By Type, By Application, By End-User, By Region - Global Forecasts till 2023

出版商 Market Research Future 商品編碼 802158
出版日期 內容資訊 英文 122 Pages
訂單完成後即時交付
價格
臉部注射器的全球市場預測:皮膚填充劑,抗老化/抗皺注射,拉皮,唇部營養護理 Facial Injectors Market Information By Type, By Application, By End-User, By Region - Global Forecasts till 2023
出版日期: 2019年01月31日內容資訊: 英文 122 Pages
簡介

本報告涵括全球臉部注射器市場相關調查,彙整市場區隔·細分區隔的詳細市場分析提供,市場成長的影響要素,收益的實際成果與預測,由於主要各區各國的目前市場規模與預測,主要企業的簡介,及競爭環境等資料。

第1章 序文

第2章 摘要整理

第3章 市場簡介

第4章 調查手法

第5章 市場動態

  • 簡介
  • 促進因素
  • 阻礙因素
  • 機會

第6章 市場要素分析

  • 波特的五力分析

第7章 全球臉部注射器市場:各類型

  • 概要
    • 簡介
    • 皮膚填充劑/可注射植入
    • 抗老化/抗皺注射

第8章 全球臉部注射器市場:各用途

  • 概要
    • 簡介
    • 臉部線蒐集營養護理
    • 拉皮
    • 唇部營養護理

第9章 全球臉部注射器市場:各終端用戶

  • 概要
    • 簡介
    • 皮膚科診所 & 美容中心
    • 醫院

第10章 全球臉部注射器市場:各地區

  • 簡介
  • 南北美洲
    • 北美
    • 南美
  • 歐洲
    • 西歐
    • 東歐
  • 亞太地區
    • 日本
    • 中國
    • 韓國
    • 印度
    • 澳洲
    • 其他的亞太地區
  • 中東·非洲
    • 中東
    • 非洲

第11章 競爭情形

  • 企業的市場佔有率分析

第12章 企業簡介

  • Galderma S.A.
  • Allergan
  • Merz Pharma
  • Valeant Pharmaceuticals
  • Integra LifeSciences Corporation
  • Sanofi
  • Sinclair Pharma
  • Suneva Medical, Inc.
  • SciVision Biotech Inc
  • Revance Therapeutics, Inc.
  • Merck KGaA
  • Ipsen Pharma

第13章 附錄

目錄

Facial Injectors Market Information By Type (Dermal Fillers/Injectable Implants, Hyaluronic Acid, Synthetic Fillers, Collagen Fillers, Anti-Aging/Anti-Wrinkle Injections, Botulinum Toxin A, Poly-L-Lactic Acid (PLLA) Microparticles), By Application (Facial Line Correction Treatment, Face-Lift, Lip Treatments), By End-User (Dermatology Clinics & Cosmetic Centers, Hospitals), By Region (Americas, Europe, Asia Pacific and The Middle East & Africa) - Global Forecasts till 2023

Market analysis

Improvement in surgeries along with the fast technological progression and the unfavorable impacts of rising contamination on facial skin are initiating interest for facial aesthetics which is adding to the development of the global facial injectors market. Popularity of various cosmetic surgical processes is one of the major driving factors of the market. However, inconveniences amid medical procedures, reactions of facial injectors and accessibility of black market for facial injectors are some of the hindering factors hampering the development of the global facial injectors market. The Global Facial Injectors market is anticipated to grow at a CAGR of 11.12% during the forecast period 2018 to 2023 by reaching the valuation of USD 14571.47 Mn by the year 2023.

Market segmentation

The global facial injectors market is segmented on the basis of its type, application, end-user and regional demand. Based on its type, the market is classified as injectable implants/ dermal fillers and anti-ageing/ anti-wrinkle injections. On the basis of its application, the global market is bifurcated into Face-Lift, Facial Line Correction Treatment, Lip Treatments. Based in its end-user industry, the global market is classified as hospitals and dermatology clinics and cosmetic centers.

Regional analysis

Geographically, the global facial injectors market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Sanofi, Revance Therapeutics Inc., leant Pharmaceuticals, Allergan, and Integra LifeSciences Corporation, Sinclair Pharma, Galderma S.A., Suneva Medical Inc., Merz Pharma, SciVision Biotech Inc, Ipsen Pharma. Merck KGaA, are some of the major players in the global facial injectors market.

Table of Contents

1 Report Prologue

2 Executive Summary

3 Market Introduction

  • 3.1 Definition
  • 3.2 Scope of the Study
  • 3.3 Assumptions & Limitations
    • 3.3.1 Assumptions
    • 3.3.2 Limitations
  • 3.4 Market Structure

4 Research Methodology

  • 4.1 Research Process
  • 4.2 Primary Research
  • 4.3 Secondary Research
  • 4.4 Market Size Estimation
  • 4.5 Forecast Model

5 Market Dynamics

  • 5.1 Introduction
  • 5.2 Drivers
    • 5.2.1 Growing Demand for Facial Aesthetic Treatments
    • 5.2.2 Technological Advancements
    • 5.2.3 Effects of Pollution
    • 5.2.4 Increasing Acceptance of Soft Tissue Fillers
    • 5.2.5 1.2.5 Growing Demand for Dermal Filler Techniques from the Asian Region
  • 5.3 Restraints
    • 5.3.1 Complications During Surgeries
    • 5.3.2 Facial Injectors Black Market
    • 5.3.3 Side-Effects Associated with Facial Injectors
  • 5.4 Opportunity
    • 5.4.1 Rising Awareness About Combination Therapies

6 Market Factor Analysis

  • 6.1 Porter's Five Forces Model
    • 6.1.1 Bargaining Power of Suppliers
    • 6.1.2 Bargaining Power of Buyers
    • 6.1.3 Threat of New Entrants
    • 6.1.4 Threat of Substitutes
    • 6.1.5 Intense Rivalry

7 Global Facial Injectors Market, By Type

  • 7.1 Overview
    • 7.1.1 Introduction
    • 7.1.2 Dermal Fillers/Injectable Implants
    • 7.1.3 Anti-Aging/Anti-Wrinkle Injections

8 Global Facial Injectors Market, By Application

  • 8.1 Overview
    • 8.1.1 Introduction
    • 8.1.2 Facial Line Correction Treatment
    • 8.1.3 Face-Lift
    • 8.1.4 Lip Treatments

9 Global Facial Injectors Market, By End-User

  • 9.1 Overview
    • 9.1.1 Introduction
    • 9.1.2 Dermatology Clinics & Cosmetic Centers
    • 9.1.3 Hospitals

10 Global Facial Injectors Market, By Region

  • 10.1 Introduction
  • 10.2 Americas
    • 10.2.1 North America
      • 10.2.1.1 U.S.
      • 10.2.1.2 Canada
    • 10.2.2 South America
  • 10.3 Europe
    • 10.3.1 Western Europe
      • 10.3.1.1 Germany
      • 10.3.1.2 U.K
      • 10.3.1.3 France
      • 10.3.1.4 Italy
      • 10.3.1.5 Spain
      • 10.3.1.6 Rest of Western Europe
    • 10.3.2 Eastern Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 Republic of Korea
    • 10.4.4 India
    • 10.4.5 Australia
    • 10.4.6 Rest of Asia Pacific
  • 10.5 The Middle East and Africa
    • 10.5.1 Middle East
    • 10.5.2 Africa

11 Competitive Landscape

  • 11.1 Company Market Share Analysis
    • 11.1.1 Introduction

12 Company Profiles

  • 12.1 Galderma S.A.
    • 12.1.1 Company Overview
    • 12.1.1 Financial Overview
    • 12.1.2 Products Offering
    • 12.1.3 Key Developments
    • 12.1.4 SWOT Analysis
    • 12.1.5 Key Strategy
  • 12.2 Allergan
    • 12.2.1 Company Overview
    • 12.2.2 Financial Overview
    • 12.2.3 Products Offering
    • 12.2.4 Key Developments
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Strategy
  • 12.3 Merz Pharma
    • 12.3.1 Company Overview
    • 12.3.2 Financial Overview
    • 12.3.3 Products Offering
    • 12.3.4 Key Developments
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Strategy
  • 12.4 Valeant Pharmaceuticals
    • 12.4.1 Company Overview
    • 12.4.2 Financial Overview
    • 12.4.3 Products Offering
    • 12.4.4 Key Developments
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Strategy
  • 12.5 Integra LifeSciences Corporation
    • 12.5.1 Company Overview
    • 12.5.2 Financial Overview
    • 12.5.3 Products Offering
    • 12.5.4 Key Developments
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Strategy
  • 12.6 Sanofi
    • 12.6.1 Company Overview
    • 12.6.2 Financial Overview
    • 12.6.3 Products Offering
    • 12.6.4 Key Developments
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Strategy
  • 12.7 Sinclair Pharma
    • 12.7.1 Company Overview
    • 12.7.2 Financial Overview
    • 12.7.3 Products Offering
    • 12.7.4 Key Developments
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Strategy
  • 12.8 Suneva Medical, Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Financial Overview
    • 12.8.3 Products Offering
    • 12.8.4 Key Developments
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Strategy
  • 12.9 SciVision Biotech Inc
    • 12.9.1 Company Overview
    • 12.9.2 Financial Overview
    • 12.9.3 Products Offering
    • 12.9.4 Key Developments
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Strategy
  • 12.1 Revance Therapeutics, Inc.
    • 12.10.1 Company Overview
    • 12.10.2 Financial Overview
    • 12.10.3 Products Offering
    • 12.10.4 Key Developments
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Strategy
  • 12.11 Merck KGaA
    • 12.11.1 Company Overview
    • 12.11.2 Financial Overview
    • 12.11.3 Products Offering
    • 12.11.4 Key Developments
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Strategy
  • 12.12 Ipsen Pharma
    • 12.12.1 Company Overview
    • 12.12.2 Financial Overview
    • 12.12.3 Products Offering
    • 12.12.4 Key Developments
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Strategy

13 Appendix

  • 13.1 Discussion Blue Print

List of Tables

  • TABLE 1 MARKET SYNOPSIS
  • TABLE 2 PRIMARY INTERVIEWS
  • TABLE 3 GLOBAL FACIAL INJECTORS MARKET BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 4 GLOBAL FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 5 GLOBAL FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 6 GLOBAL FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 7 GLOBAL FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 8 GLOBAL FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 9 GLOBAL FACIAL INJECTORS MARKET BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 10 GLOBAL FACIAL INJECTORS MARKET FOR FACIAL LINE CORRECTION TREATMENT, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 11 GLOBAL FACIAL INJECTORS MARKET FOR FACE-LIFT, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 12 GLOBAL FACIAL INJECTORS MARKET FOR LIP TREATMENTS, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 13 GLOBAL FACIAL INJECTORS MARKET BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 14 GLOBAL FACIAL INJECTORS MARKET FOR DERMATOLOGY CLINICS & COSMETIC CENTERS, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 15 GLOBAL FACIAL INJECTORS MARKET FOR HOSPITALS, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 16 GLOBAL FACIAL INJECTORS MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 17 AMERICAS: FACIAL INJECTORS MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 18 AMERICAS FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 19 AMERICAS FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 20 AMERICAS FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 21 AMERICAS FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 22 AMERICAS FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 23 AMERICAS FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 24 NORTH AMERICA FACIAL INJECTORS MARKET, BY COUNTRY, 2015-2023 (USD MILLION)
  • TABLE 25 NORTH AMERICA FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 26 NORTH AMERICA FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 27 NORTH AMERICA FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 28 NORTH AMERICA FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 29 NORTH AMERICA FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 30 NORTH AMERICA FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 31 U.S. FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 32 U.S. FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 33 U.S. FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 34 U.S. FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 35 U.S. FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 36 U.S. FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 37 CANADA FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 38 CANADA FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 39 CANADA FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 40 CANADA FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 41 CANADA FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 42 CANADA FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 43 SOUTH AMERICA FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 44 SOUTH AMERICA FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 45 SOUTH AMERICA FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 46 SOUTH AMERICA FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 47 SOUTH AMERICA FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 48 SOUTH AMERICA FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 49 EUROPE: FACIAL INJECTORS MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 50 EUROPE FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 51 EUROPE FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 52 EUROPE FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 53 EUROPE FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 54 EUROPE FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 55 EUROPE FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 56 WESTERN EUROPE: FACIAL INJECTORS MARKET, BY COUNTRY, 2015-2023 (USD MILLION)
  • TABLE 57 WESTERN EUROPE FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 58 WESTERN EUROPE FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 59 WESTERN EUROPE FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 60 WESTERN EUROPE FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 61 WESTERN EUROPE FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 62 WESTERN EUROPE FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 63 GERMANY FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 64 GERMANY FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 65 GERMANY FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 66 GERMANY FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 67 GERMANY FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 68 GERMANY FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 69 U.K FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 70 U.K FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 71 U.K FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 72 U.K FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 73 U.K FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 74 U.K FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 75 FRANCE FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 76 FRANCE FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 77 FRANCE FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 78 FRANCE FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 79 FRANCE FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 80 FRANCE FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 81 ITALY FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 82 ITALY FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 83 ITALY FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 84 ITALY FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 85 ITALY FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 86 ITALY FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 87 SPAIN FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 88 SPAIN FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 89 SPAIN FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 90 SPAIN FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 91 SPAIN FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 92 SPAIN FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 93 REST OF WESTERN EUROPE FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 94 REST OF WESTERN EUROPE FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 95 REST OF WESTERN EUROPE FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 96 REST OF WESTERN EUROPE FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 97 REST OF WESTERN EUROPE FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 98 REST OF WESTERN EUROPE FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 99 EASTERN EUROPE FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 100 EASTERN EUROPE FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 101 EASTERN EUROPE FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 102 EASTERN EUROPE FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 103 EASTERN EUROPE FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 104 EASTERN EUROPE FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 105 ASIA PACIFIC FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 106 ASIA PACIFIC FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 107 ASIA PACIFIC FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 108 ASIA PACIFIC FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 109 ASIA PACIFIC FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 110 ASIA PACIFIC FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 111 JAPAN FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 112 JAPAN FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 113 JAPAN FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 114 JAPAN FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 115 JAPAN FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 116 JAPAN FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 117 CHINA FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 118 CHINA FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 119 CHINA FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 120 CHINA FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 121 CHINA FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 122 CHINA FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 123 REPUBLIC OF KOREA FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 124 REPUBLIC OF KOREA FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 125 REPUBLIC OF KOREA FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 126 REPUBLIC OF KOREA FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 127 REPUBLIC OF KOREA FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 128 REPUBLIC OF KOREA FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 129 INDIA FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 130 INDIA FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 131 INDIA FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 132 INDIA FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 133 INDIA FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 134 INDIA FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 135 AUSTRALIA FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 136 AUSTRALIA FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 137 AUSTRALIA FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 138 AUSTRALIA FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 139 AUSTRALIA FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 140 AUSTRALIA FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 141 REST OF ASIA PACIFIC FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 142 REST OF ASIA PACIFIC FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 143 REST OF ASIA PACIFIC FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 144 REST OF ASIA PACIFIC FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 145 REST OF ASIA PACIFIC FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 146 REST OF ASIA PACIFIC FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 147 MIDDLE EAST AND AFRICA FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 148 MIDDLE EAST AND AFRICA FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 149 MIDDLE EAST AND AFRICA FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 150 MIDDLE EAST AND AFRICA FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 151 MIDDLE EAST AND AFRICA FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 152 MIDDLE EAST AND AFRICA FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 153 MIDDLE EAST FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 154 MIDDLE EAST FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 155 MIDDLE EAST FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 156 MIDDLE EAST FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 157 MIDDLE EAST FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 158 MIDDLE EAST FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)
  • TABLE 159 AFRICA FACIAL INJECTORS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 160 AFRICA FACIAL INJECTORS MARKET FOR DERMAL FILLERS/INJECTABLE IMPLANTS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 161 AFRICA FACIAL INJECTORS MARKET FOR SYNTHETIC FILLERS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 162 AFRICA FACIAL INJECTORS MARKET FOR ANTI-AGING/ANTI-WRINKLE INJECTIONS BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 163 AFRICA FACIAL INJECTORS MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 164 AFRICA FACIAL INJECTORS MARKET, BY END-USER, 2015-2023 (USD MILLION)

List of Figures

  • FIGURE 1 GLOBAL FACIAL INJECTORS MARKET: MARKET STRUCTURE
  • FIGURE 2 RESEARCH PROCESS
  • FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH
  • FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL FACIAL INJECTORS MARKET
  • FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL FACIAL INJECTORS MARKET
  • FIGURE 6 GLOBAL FACIAL INJECTORS MARKET, BY TYPE, 2017 (% SHARE)
  • FIGURE 7 GLOBAL FACIAL INJECTORS MARKET, BY TYPE, 2017 & 2023
  • FIGURE 8 GLOBAL FACIAL INJECTORS MARKET, BY APPLICATION, 2017 (% SHARE)
  • FIGURE 9 GLOBAL FACIAL INJECTORS MARKET, BY APPLICATION, 2017 & 2023
  • FIGURE 10 GLOBAL FACIAL INJECTORS MARKET, BY END-USER, 2017 (% SHARE)
  • FIGURE 11 GLOBAL FACIAL INJECTORS MARKET, BY END-USER, 2017 & 2023
  • FIGURE 12 GLOBAL FACIAL INJECTORS MARKET, BY REGION, 2017 & 2023(USD MILLION)
  • FIGURE 13 GLOBAL FACIAL INJECTORS MARKET, BY REGION, 2017 (% SHARE)
  • FIGURE 14 AMERICAS: FACIAL INJECTORS MARKET SHARE, BY REGION, 2017 (% SHARE)
  • FIGURE 15 EUROPE: FACIAL INJECTORS MARKET SHARE, BY REGION, 2017 (% SHARE)
  • FIGURE 16 ASIA PACIFIC: FACIAL INJECTORS MARKET SHARE, BY COUNTRY, 2017 (% SHARE)
  • FIGURE 17 THE MIDDLE EAST AND AFRICA: FACIAL INJECTORS MARKET SHARE, BY REGION, 2017 (% SHARE)
  • FIGURE 18 GLOBAL FACIAL INJECTORS MARKET, MARKET SHARE ANALYSIS 2017 (% SHARE)